Interferon Alfa-2B

ATC L03AB05 · 6 markets · 92 records

Interferon Alfa-2B 6 markets · 92 records Forms

CN 63 records · 23 strengths

  • 300 万IUinjection万复因干扰素α2b凯孚、利分能、安达芬、尤尼隆、远策素、长生扶康
  • 1.2 mLinjection甘乐能干扰素α2b also in GB
  • 1 mLinjection凯因益生干扰素α2b安福隆、安达芬、Manufacturer: 长春海伯尔生物技术有限责任公司 also in GB
  • 500 万IUinjection利分能干扰素α2b安达芬、远策素、长生扶康
  • 100 万IUinjection利分能干扰素α2b安达芬、远策素、长生扶康
  • 600 万IUinjection万复因干扰素α2b安达芬
  • 0.6 mLinjection凯因益生干扰素α2bManufacturer: 长春海伯尔生物技术有限责任公司
  • 0.5 mLinjection凯因益生干扰素α2bManufacturer: 长春海伯尔生物技术有限责任公司
  • 0.3 mLinjection凯因益生干扰素α2bManufacturer: 长春海伯尔生物技术有限责任公司
  • 50 万IUeffervescentManufacturer: 北京凯因科技股份有限公司 ×2
  • 80 万IUcapsule辛复宁干扰素α2b
  • 200 万IUliquid安达芬干扰素α2b
Other strengths: 11 · 3 dosage forms Otras concentraciones: 11 · 3 formas farmacéuticas 其余规格 11 个 · 涉及 3 种剂型 其餘規格 11 個 · 涉及 3 種劑型
liquid · 1100 万IU
suppository · 250 万IU10 万IU
topical · 810,000 mg5,000 mg400 万IU200 万IU100 万IU20 mL10 mL10 万IU

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

GB 9 records · 4 strengths

  • 1.2 mLinjectionIntronA 18million units/1.2ml solution for injection multidose pensIntronA 30million units/1.2ml solution for injection multidose pens、IntronA 60million units/1.2ml solution for injection multidose pens、Viraferon 18million units/1.2ml solution for injection multidose pens、Viraferon 30million units/1.2ml solution for injection multidose pens also in CN
  • 1 mLinjectionIntronA 10million units/1ml solution for injection vials also in CN
  • 3 mLinjectionViraferon 18million units/3ml solution for injection multidose vials
  • 2.5 mLinjectionIntronA 25million units/2.5ml solution for injection multidose vials
The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.